ASX Share rice
Sat 08 Aug 2020 - 06:42:pm (Sydney)

MEB Share Price

MEDIBIO LIMITEDMEBHealth Care Equipment & Services

MEB Company Information

Name:

Medibio Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Health Care Technology

GIC Sub Industry:

Health Care Technology

Address:

8696 Eagle Creek Circle Savage MN United States 55378

Phone:

952-222-0551

MD & Director:

Mr. Claude Solitario

Joint Company Sec. & Director:

Ms. Melanie Jaye Leydin C.A., B.Bus, CA

Operations & Account Mang.:

Ms. Renee Stanton-Horne

Investor Relations Director:

Ms. Stephanie Ottens

PR Director:

Mr. Josh Purdy

Company Overview:

Medibio Limited, a health technology company, engages in the development of diagnostic systems for mental health illnesses in Australia and the United States. It is involved in the research, development, and commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. Medibio Limited has a research agreement with the Department of Biomedical Sciences of Humanitas University for the development of mental health software products. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was founded in 1998 and is headquartered in Savage, Minnesota.

MEB Share Price Information

Shares Issued:

1.09B

Market Capitalisation:

$13.14M

Revenue (TTM):

$1.47M

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.03

Operating Margin (TTM):

$-3.02

Return On Assets (TTM):

$-0.18

Return On Equity (TTM):

$-0.43

Quarterly Revenue Growth (YOY):

-0.77

Gross Profit(TTM):

$3.88M

Diluted Earnings Per Share (TTM):

$-0.01

MEB CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-1,085,031

Change To Liabilities:

$-1,860,555

Total Cashflow From Investing Activities:

$-1,057,207

Net Borrowings:

$2.34M

Net Income:

$-6,587,039

Total Cash From Operating Activities:

$-6,857,674

Other Cashflow From Investing Activities:

$54.01K

Change To Account Receivables:

$1.65M

Sale Purchase Of Stock:

$-140,877

Capital Expenditures:

$1.14M

MEB Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-6,587,039

Net Income:

$-6,587,039

Gross Profit:

$138.54K

Operating Income:

$-9,799,096

Other Operating Expenses:

$5.01M

Interest Expense:

$13.93K

Total Revenue:

$364.63K

Total Operating Expenses:

$9.94M

Cost Of Revenue:

$226.09K

MEB Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$11.66M

Total Liabilities:

$4.70M

Total Stockholder Equity:

$8.60M

Other Current Liabilities:

$797.08K

Total Assets:

$13.30M

Common Stock:

$84.42M

Other Current Assets:

$184.05K

Retained Earnings:

$-80,499,301

Other Assets:

$2.89M

Cash:

$1.33M

Total Current Liabilities:

$4.70M

Short-Term Debt:

$2.75M

Net Tangible Assets:

$-281,044

Total Current Assets:

$1.53M

Net Receivables:

$14.87K

Short-Term Investments:

$11.77M

Accounts Payable:

$1.01M

Non Currrent Assets (Other):

$107.23K

Short-Term Investments:

$11.77

Non Current Liabilities Total:

$0

MEB Share Price History

MEB News

10 Mar, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
01 Oct, 2019
If you own shares in Medibio Limited (ASX:MEB) then it's worth thinking about how it contributes to the volatility of...